Alveolar-capillary Reserve After Exercise in Chronic Obstructive Pulmonary Disease (COPD) (COP-DTPA) - Trial NCT06287476
Access comprehensive clinical trial information for NCT06287476 through Pure Global AI's free database. This phase not specified trial is sponsored by Rigshospitalet, Denmark and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 32 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Rigshospitalet, Denmark
Timeline & Enrollment
N/A
Mar 15, 2024
Mar 15, 2025
Primary Outcome
Rest-to-exercise pulmonary DTPA clearance change after exercise in COPD vs. controls
Summary
It is unknown whether individuals with COPD exhibit abnormal alveolar-capillary breaching
 during exercise, and whether this contributes to exertional dyspnoea. The aim of this study
 is to investigate whether individuals with COPD exhibit an abnormal increase in
 alveolar-capillary breaching during exertion, as indicated by an increase alveolar-capillary
 permeability with a concomitantly exacerbated increase in lung tissue mass.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06287476
Non-Device Trial